|
Downgrade
| ShowHide Related Items >><< - 11/21/22
- First Foundation announces CEO Scott Kavanaugh named president
- 11/08/22
- First Foundation says president DePillo to leave, CFO Thompson named interim
- 01/03/23 Stephens
- Castle Biosciences, Academy Sports on Stephens 'Best Ideas' list for 2023
- 10/26/22 DA Davidson
- First Foundation downgraded to Neutral from Buy at DA Davidson
- 07/27/22 B. Riley
- First Foundation price target raised to $23 from $21 at B. Riley
- 07/11/22 B. Riley
- First Foundation downgraded to Neutral from Buy at B. Riley
- 01/26/23
- First Foundation reports Q4 EPS 31c, consensus 31c
- 10/25/22
- First Foundation reports Q3 EPS 51c, consensus 51c
- 09/21/22
- Seventeen new option listings on September 21st
|
|
Earnings
| ShowHide Related Items >><< - $301.39 /
-11.73 (-3.75%) - 02/02/23
- Managed care stocks pressured after CMS' preliminary Medicare Advantage rates
- 01/12/23
- California AG files suit against drugmakers, PBMs over insulin prices
- 12/06/22
- Walmart to pay $500,000 over workers' compensation prescription procedures
- 11/07/22
- WBA to invest $3.5B to support VillageMD acquisition of Summit Healt-CityMD
- $301.39 /
-11.73 (-3.75%) - 01/31/23 JPMorgan
- Medicare Advantage final rule more favorable than feared, says JPMorgan
- 01/03/23 Wells Fargo
- Wells Fargo downgrades Cigna to Equal Weight, lowers price target to $355
- 01/03/23 Wells Fargo
- Cigna downgraded to Equal Weight from Overweight at Wells Fargo
- 11/23/22 Morgan Stanley
- Walgreens Boots Alliance assumed with an Underweight at Morgan Stanley
- $301.39 /
-11.73 (-3.75%) - 06:02 Today
- Cigna reports Q4 adjusted EPS $4.96, consensus $4.86
- 02/02/23
- Notable companies reporting before tomorrow's open
- 02/02/23
- Notable companies reporting before tomorrow's open
- 11/03/22
- Cigna raises FY22 adjusted EPS view to at least $23.10 from at least $22.90
- $301.39 /
-11.73 (-3.75%) - 01/27/23
- Cigna sues CVS Health, Amy Bricker for violating noncompete, Bloomberg Law says
- 11/29/22
- Managed care company returns will be tough to keep replicating, WSJ says
- 11/07/22
- Walgreens-backed VillageMD close to $9B deal with Summit, WSJ reports
- 08/18/22
- White House plans for end of COVID-19 vaccine coverage, WSJ reports
- $301.39 /
-11.73 (-3.75%) - 01/27/23
- What You Missed On Wall Street This Morning
- 11/23/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/21/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/03/22
- Fly Intel: Pre-market Movers
- $301.39 /
-11.73 (-3.75%) - 01/13/23
- Early notable gainers among liquid option names on January 13th
|
|
Syndicate
| ShowHide Related Items >><< QNRX Quoin Pharmaceuticals - 12/13/22
- Quoin announces dosing of first patient in trial in Netherton Syndrome
- 11/03/22
- Quoin Pharmaceuticals announces updated Q3 conference call timing
- 10/18/22
- Quoin announces plans to initiate second trial in Netherton syndrome patients
- 09/13/22
- Quoin Pharmaceuticals establishes patient specific website for ongoing study
QNRX Quoin Pharmaceuticals - 09/07/22 Alliance Global Partners
- Quoin Pharmaceuticals initiated with a Buy at Alliance Global Partners
- 08/19/22 JMP Securities
- Quoin Pharmaceuticals price target lowered to $15 from $100 at JMP Securities
- 08/19/22 Maxim
- Quoin Pharmaceuticals price target lowered to $10 from $25 at Maxim
- 05/06/22 Ladenburg
- Ladenburg starts Quoin Pharmaceuticals at Buy with $2 price target
QNRX Quoin Pharmaceuticals - 11/10/22
- Quoin Pharmaceuticals reports Q3 ADS (94c) vs ($5.84) last year
- 08/18/22
- Quoin Pharmaceuticals reports Q2 EPS ($3.24) vs. ($18.05) last year
|
|
Downgrade
| ShowHide Related Items >><< - 10/25/22
- Coinbase launches USDC institutional rewards program with MakerDAO
- 10/24/22
- Hexcel did not repurchase any common stock during Q3
- 01/30/23 Jefferies
- Hexcel price target raised to $70 from $60 at Jefferies
- 01/30/23 Wells Fargo
- Hexcel price target raised to $70 from $60 at Wells Fargo
- 01/27/23 Truist
- Hexcel price target raised to $59 from $53 at Truist
- 01/09/23 Truist
- Hexcel price target raised to $53 from $52 at Truist
- 01/25/23
- Hexcel sees FY23 EPS $1.70-$1.90, consensus $1.82
- 01/25/23
- Hexcel reports Q4 EPS 40c, consensus 32c
- 10/24/22
- Hexcel narrows FY22 adjusted EPS view to $1.12-$1.24 from $1.00-$1.24
- 10/24/22
- Hexcel reports Q3 adjusted EPS 33c, consensus 33c
- 01/25/23
- Fly Intel: After-Hours Movers
|
|
Downgrade
| ShowHide Related Items >><< - 10/10/22
- Camden Property estimates $1.0M in expenses related to Hurricane Ian
- 09/30/22
- Camden Property says early reports indicate minor damage from Hurricane Ian
- 09/30/22
- Camden Property provides update on Hurricane Ian
- 02/02/23 Piper Sandler
- Camden Property downgraded to Neutral from Overweight at Piper Sandler
- 01/10/23 Mizuho
- Camden Property upgraded to Buy from Neutral at Mizuho
- 01/04/23 Deutsche Bank
- Camden Property price target lowered to $140 from $153 at Deutsche Bank
- 12/15/22 UBS
- Camden Property initiated with a Buy at UBS
- 02/02/23
- Camden Property sees Q1 FFO $1.63-$1.67, consensus $1.75
- 02/02/23
- Camden Property sees FY23 FFO $6.70-$7.00, consensus $7.17
- 02/02/23
- Camden Property reports Q4 FFO $1.74, consensus $1.74
- 10/27/22
- Camden Property see FY22 FFO $6.57-$6.61, consensus $6.63
|
|
Downgrade
| ShowHide Related Items >><< - 02/02/23
- Ford sees FY23 capital expenditures $8B-$9B
- 02/02/23
- Ford down 6% after Q4 earnings report
- 02/02/23
- Ford declares regular Q1 dividend of 15c, supplemental dividend of 65c
- 02/02/23
- Ford reports January U.S. sales up 2% to 146,356 vehicles
- 01/25/23 JPMorgan
- Ford price target lowered to $15 from $16 at JPMorgan
- 01/11/23 Goldman Sachs
- Goldman continues to prefer Tesla and GM among automakers
- 12/21/22 Morgan Stanley
- Tesla shedding $600B of value presents buying opportunity, says Morgan Stanley
- 12/05/22 Jefferies
- Fox Factory price target raised to $135 from $120 at Jefferies
- 02/02/23
- Ford sees FY23 adjusted EBIT of $9B-$11B
- 02/02/23
- Ford reports Q4 adjusted EPS 51c, consensus 62c
- 02/02/23
- Notable companies reporting after market close
- 10/26/22
- Ford reports Q3 adjusted EPS 39c, consensus 27c
- 02/02/23
- Ford's Jan. U.S. sales increased 2% y/y, saw 'record' EV sales, Bloomberg says
- 01/24/23
- Ford in discussions to sell German factory to BYD, WSJ reports
- 01/23/23
- Union says Ford to slash up to 3,200 European jobs, Reuters reports
- 01/23/23
- Ford planning massive layoffs overseas in favor of EV development, Electrek says
- 02/02/23
- Fly Intel: After-Hours Movers
- 01/30/23
- What You Missed On Wall Street On Monday
- 01/30/23
- What You Missed On Wall Street This Morning
- 01/30/23
- Here's what Wall St. experts are saying about these automakers ahead of earnings
- 02/02/23
- Ford options imply 5.2% move in share price post-earnings
- 01/17/23
- Ford put volume heavy and directionally bearish
- 12/30/22
- Notable open interest changes for December 30th
- 12/19/22
- Unusually active option classes on open December 19th
|
|
Initiation
|
BofA analyst Anna Liznul… ShowHide Related Items >><< - 12/06/22
- Herbalife Nutrition falls -19.5%
- 12/06/22
- Herbalife Nutrition falls -16.6%
- 12/06/22
- Herbalife Nutrition falls -15.0%
- 12/05/22
- Herbalife Nutrition falls 10% to $15.70 after offering $250M in convertible debt
- 11/01/22 B. Riley
- Herbalife Nutrition price target lowered to $31 from $38 at B. Riley
- 11/01/22 Citi
- Herbalife Nutrition price target lowered to $26 from $30 at Citi
- 10/05/22 Citi
- Herbalife Nutrition price target lowered to $30 from $36 at Citi
- 08/03/22 B. Riley
- Herbalife Nutrition price target lowered to $38 from $41 at B. Riley
- 10/31/22
- Herbalife Nutrition reports Q3 EPS 91c, consensus 74c
- 12/06/22
- What You Missed On Wall Street On Tuesday
- 12/06/22
- What You Missed On Wall Street This Morning
- 12/06/22
- Fly Intel: Pre-market Movers
- 12/05/22
- Fly Intel: After-Hours Movers
- 12/23/22
- Herbalife put volume heavy and directionally bearish
- 10/31/22
- Herbalife options imply 8.4% move in share price post-earnings
|
|
Hot Stocks
|
Vyant Bio announced that… ShowHide Related Items >><< - 01/04/23
- Vyant Bio engages LifeSci Capital to explore strategic alternatives
- 11/16/22
- Vyant Bio regains compliance with Nasdaq minimum bid requirement
- 11/07/22
- Vyant Bio teams up with IRSF to host local viewing party
- 11/03/22
- Vyant Bio sells vivoPharm subsidiary to Reaction for $5.5M
- 10/04/22 Ascendiant
- Vyant Bio initiated with a Buy at Ascendiant
- 11/15/22
- Vyant Bio reports Q3 EPS (59c) vs (77c) last year
- 08/22/22
- Vyant Bio reports Q2 EPS (20c) vs (14c) last year
- 01/05/23
- Fly Intel: Pre-market Movers
|
|
Recommendations
|
Oppenheimer analyst Jason… ShowHide Related Items >><< - $108.77 /
+7.375 (+7.27%) - 02/02/23
- Alphabet says started bringing revenue sharing to YouTube Shorts
- 02/02/23
- Alphabet reports Q4 Google Cloud revenue $7.3B vs. $5.54B last year
- 02/02/23
- Alphabet taking actions to optimize global office space
- 02/01/23
- 'Tomb Raider Reloaded' coming to Google Play, iOS, Netflix on February 14
- $108.77 /
+7.375 (+7.27%) - 04:30 Today Piper Sandler
- Alphabet price target lowered to $120 from $122 at Piper Sandler
- 02/02/23 Morgan Stanley
- Meta Platforms price target raised to $190 from $130 at Morgan Stanley
- 01/31/23 BofA
- Alphabet price target raised to $119 at BofA ahead of earnings
- 01/30/23 KeyBanc
- Trade Desk price target lowered to $55 from $56 at KeyBanc
- $108.77 /
+7.375 (+7.27%) - 02/02/23
- Alphabet reports Q4 EPS $1.05, consensus $1.18
- 02/02/23
- Notable companies reporting after market close
- 10/25/22
- Alphabet reports Q3 EPS $1.06, consensus $1.25
- 10/25/22
- Notable companies reporting after market close
- $108.77 /
+7.375 (+7.27%) - 02/02/23
- Democratic senator joins calls to ban TikTok, WSJ reports
- 02/01/23
- GoodRx to pay $1.5M fine over sharing health data, Bloomberg Law reports
- 02/01/23
- Google testing ChatGPT-like products, including 'Apprentice Bard,' CNBC reports
- 01/31/23
- Reels sharing revenue with creators hotly debated within Meta, Information says
- $108.77 /
+7.375 (+7.27%) - 02/02/23
- What You Missed On Wall Street On Thursday
- 02/02/23
- What You Missed On Wall Street This Morning
- 02/02/23
- What Wall Street is saying about Alphabet ahead of earnings
- 02/01/23
- #SocialStocks: Meta circumvents FTC challenge and will acquire Within Unlimited
- $108.77 /
+7.375 (+7.27%) - 02/02/23
- Alphabet options imply 5.9% move in share price post-earnings
- 01/20/23
- Unusually active option classes on open January 20th
- 12/14/22
- Alphabet put buyer realizes 126% same-day gains
- 11/02/22
- Alphabet put buyer realizes 98% same-day gains
|
|
Earnings
| ShowHide Related Items >><< - $301.39 /
-11.73 (-3.75%) - 02/02/23
- Managed care stocks pressured after CMS' preliminary Medicare Advantage rates
- 01/12/23
- California AG files suit against drugmakers, PBMs over insulin prices
- 12/06/22
- Walmart to pay $500,000 over workers' compensation prescription procedures
- 11/07/22
- WBA to invest $3.5B to support VillageMD acquisition of Summit Healt-CityMD
- $301.39 /
-11.73 (-3.75%) - 01/31/23 JPMorgan
- Medicare Advantage final rule more favorable than feared, says JPMorgan
- 01/03/23 Wells Fargo
- Wells Fargo downgrades Cigna to Equal Weight, lowers price target to $355
- 01/03/23 Wells Fargo
- Cigna downgraded to Equal Weight from Overweight at Wells Fargo
- 11/23/22 Morgan Stanley
- Walgreens Boots Alliance assumed with an Underweight at Morgan Stanley
- $301.39 /
-11.73 (-3.75%) - 02/02/23
- Notable companies reporting before tomorrow's open
- 02/02/23
- Notable companies reporting before tomorrow's open
- 11/03/22
- Cigna raises FY22 adjusted EPS view to at least $23.10 from at least $22.90
- 11/03/22
- Cigna reports Q3 adjusted EPS $6.04, consensus $5.71
- $301.39 /
-11.73 (-3.75%) - 01/27/23
- Cigna sues CVS Health, Amy Bricker for violating noncompete, Bloomberg Law says
- 11/29/22
- Managed care company returns will be tough to keep replicating, WSJ says
- 11/07/22
- Walgreens-backed VillageMD close to $9B deal with Summit, WSJ reports
- 08/18/22
- White House plans for end of COVID-19 vaccine coverage, WSJ reports
- $301.39 /
-11.73 (-3.75%) - 01/27/23
- What You Missed On Wall Street This Morning
- 11/23/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/21/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/03/22
- Fly Intel: Pre-market Movers
- $301.39 /
-11.73 (-3.75%) - 01/13/23
- Early notable gainers among liquid option names on January 13th
|
